Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling
Concurrent Alcohol Dependence and Pathological Gambling
About this trial
This is an interventional treatment trial for Concurrent Alcohol Dependence and Pathological Gambling focused on measuring naltrexone, alcohol, gambling, concurrent
Eligibility Criteria
Inclusion Criteria: DSM-IV diagnosis of alcohol abuse and dependence Diagnosis of pathological gambling Drinking on at least 50% of the days in the preceding month Gambling at least weekly in the month prior to assessment Exclusion Criteria: Dependence or abuse of any other psychoactive substances (except for nicotine dependence) Concurrent diagnoses of any other psychiatric disorder, Serious medical illness Laboratory evidence of significant hepatocellular injury Use of disulfiramuse and/or opioid-containing medications Psychosocial crisis Pregnancy Inability to read or write English. Poor motivation to change alcohol or gambling behavior
Sites / Locations
- Centre for Addiction and Mental Health
- National Public Health Institute